Clinical Scorecard: Impact of Body Composition on the Bone-Vascular Relationship in Osteoporosis Revealed Through AI-Driven CT Analysis in COPD Patients
At a Glance
Category
Detail
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Key Mechanisms
Altered body composition influences disease phenotype and prognosis, affecting systemic processes such as inflammation and metabolic dysfunction.
Target Population
COPD patients, particularly those with osteoporosis and altered body composition.
Care Setting
Clinical settings utilizing AI-driven CT analysis for body composition assessment.
Key Highlights
COPD affects approximately 384 million individuals globally, with a prevalence of 11.7%.
Osteoporosis prevalence in COPD patients is about 38%, with vertebral fractures affecting more than 20%.
Sarcopenia affects 25-30% of COPD patients, indicating significant body composition alterations.
AI-driven CT analysis provides insights into the bone-vascular relationship in COPD patients.
Guideline-Based Recommendations
Diagnosis
Utilize AI-driven CT analysis for assessing body composition and related comorbidities in COPD.
Management
Adopt personalized approaches to COPD management considering body composition and comorbidities.
Monitoring & Follow-up
Regularly evaluate body composition and osteoporosis risk in COPD patients.
Risks
Monitor for increased prevalence of osteoporosis and coronary artery disease in COPD patients with altered body composition.
Patient & Prescribing Data
COPD patients with varying body composition phenotypes.
Consider the impact of body composition on treatment response and disease progression.
Clinical Best Practices
Implement comprehensive assessments of body composition in COPD management.
Utilize standardized imaging protocols for CT scans across clinical sites.
by Bettina K. Budai, Andreas Wagner, Ondrej Havlicek, Philip Konietzke, Franziska C. Trudzinski, Jürgen Biederer, Claus P. Heußel, Hans-Ulrich Kauczor, Viktoria Palm
Narrative review describes how physiologic stressors accumulate from induction through postintubation care and may contribute to cardiovascular deterioration during airway management.
Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.
